Breast cancers are characterized into major classifications based on signaling receptor expression profile: hormone receptor positive estrogen receptor and/or progesterone receptor (ER and/or PR), human growth factor receptor-2 (HER2) positive, or triple-negative breast cancer (ER/PR/HER2 receptor negative or TNBC) [3]. This evidence concerns the gene NR4A1 and breast cancer.